Nasdaq to Hold First Quarter 2024 Investor Conference Call
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its First Quarter 2024 financial results announcement.
Who: | Nasdaq’s CEO, CFO, and additional members of its senior management team |
What: | Review Nasdaq’s First Quarter 2024 financial results |
When: | Thursday, April 25, 2024 |
Results Call: 8:00 AM Eastern | |
Senior management will be available for questions from the investment community following prepared remarks.
All participants can access the conference via webcast through the Nasdaq Investor Relations website at http://ir.nasdaq.com/.
Note: The press release for the First Quarter 2024 results will be posted on the Nasdaq Investor Relations website at http://ir.nasdaq.com/ on Thursday, April 25, 2024 at approximately 7:00 AM Eastern.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.
Media Relations Contact:
Nick Eghtessad
+1.929.996.8894
Nick.Eghtessad@Nasdaq.com
Investor Relations Contact:
Ato Garrett
+1.212.401.8737
Ato.Garrett@Nasdaq.com
-NDAQF-
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth